• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Glassia
    / Kamada


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    50 ml

    not in the basket chart 19644

    Dosage

    Administer 60 mg/kg body weight once weekly by intravenous infusion.
    See prescribing information for full details.


    Indications

    For chronic augmentation and maintenance therapy in individuals with congenital deficiency of alpha1-proteinase inhibitor (Alpha1-PI), also known as alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.


    Contra-Indications

    Immunoglobulin A (IgA) deficient patients with antibodies against IgA. Individuals with a history of severe immediate hypersensitivity reactions, including anaphylaxis, to Alpha1-PI products.


    Special Precautions

    Pregnancy and lactation: Pregnancy Category C: Should be given to a pregnant woman only if clearly needed. Caution should be exercised when administered to a nursing woman.
    See prescribing information for full details.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Pregnancy and Lactation

    Pregnancy and lactation: Pregnancy Category C: Should be given to a pregnant woman only if clearly needed.
    Lactation: Caution should be exercised when administered to a nursing woman.
    See prescribing information for full details.


    Manufacturer
    Kamada Ltd.
    Licence holder
    CLOSE